Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus

Assure Holdings Announces Cost Reduction Plan to Accelerate Path to Profitability

DENVER, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ: IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, today announced a cost reduction plan (the "Plan") intended to accelerate its path to EBITDA profitability and positive operating cash flow. 

The Plan is expected to reduce operating costs by more than $2.0 million on an annualized basis. Key elements include:

The reduction in employee compensation cost directly benefits the Company's average cost of delivery increasing gross margin for each surgery.

The Plan also includes revenue expansion as the Company eliminates legacy revenue sharing agreements under historic master services agreement ("MSA") and professional network entities ("PNE"). As a result, going forward, the Company will retain all revenue from the professional bill. The Company has successfully terminated more than 50% of these legacy MSA agreements and PNEs and expects to complete this project by the end of the first quarter. Assure anticipates an increase of more than $200,000 a month in revenue and gross margin during 2023 as the Company has borne the cost to support these businesses but was only receiving a portion of the revenue under MSA agreements.

These cost reductions and revenue enhancements are in addition to those previously completed during 2022 including:

John A. Farlinger, Assure's executive chairman and CEO, said, "We are continuing to take a more measured approach to the allocation of capital, prioritizing the generation of sustainable positive operating cash even if it means slightly slower growth. Our plan is expected to reduce our operating costs by approximately $2.0 million on an annualized basis to help fund long-term improvements that are expected to accelerate our path to profitability on an EBITDA basis. We are focusing our resources on initiatives that we believe will put the Company on track for sustainable success."

About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients' neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure's mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company's website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain "forward-looking statements" within the meaning of applicable securities laws, including, but not limited to comments with respect to: our ability to achieve positive operating cash flow and profitability, the anticipated cost savings of the cost reduction plan, anticipated increase of $200,000 per month in revenue and gross margin in 2023, anticipated improvements in gross margin for surgeries, the potential benefits of the strategic actions in decreasing cash costs, accelerating cash collections, the Company's business being more profitable on an EBITDA basis, the effect of discontinuing operations in unprofitable markets and expectations with respect to the Company's growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company's operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company's EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Investor Contact
Brett Maas, Managing Principal, Hayden IR
[email protected]
(646) 536-7331

These press releases may also interest you

at 16:41
Stratolaunch LLC announces it has successfully completed a third captive carry flight of the Talon-A separation test vehicle, TA-0. The flight was the tenth for the company's launch platform Roc and marks the beginning of routine flight operations in...

at 14:32
Jobma has announced a significant update that will leverage the power of Artificial Intelligence to provide...

at 14:25
Hindu University of America (http://www.hua.edu) in association with Hindus of Greater Houston (HGH) hosted a Friends of HUA Gala evening on Sunday,...

at 14:16
Wildly Different Team Building Experiences is celebrating their 20th year in business on April 1, 2023. Since opening their doors in 2003, Wildly Different has become a top team building company working with worldwide corporations. From their...

at 12:20
REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu Chemical Co., Ltd. (4755.TW) have entered a licensing agreement to...

at 11:00
SecSee, the highly anticipated stealth security platform that enables DevSecOps to consolidate and prioritize vulnerabilities across the software supply chain, announced its launch today....

News published on 9 february 2023 at 08:30 and distributed by: